Heron Therapeutics (HRTX) CDO converts RSUs and withholds shares
Rhea-AI Filing Summary
Heron Therapeutics EVP and Chief Development Officer William P. Forbes converted a total of 23,463 restricted stock units into an equal number of common shares on July 30–31, 2026, under time-based vesting schedules. To cover exercise price or tax obligations, 6,674 shares of common stock were withheld at $0.50 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 16,789 shares
Net Buy
6 txns
Insider
Forbes William P
Role
EVP, Chief Development Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F3 | 11,694 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 11,694 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 3,326 | $0.50 | $2K |
| Exercise | Restricted Stock Units F2 | 11,769 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 11,769 | -- | -- |
| Exercise Price or Tax Liability | Common Stock | 3,348 | $0.50 | $2K |
Holdings After Transaction:
Restricted Stock Units — 281,720 shares (Direct);
Common Stock — 241,173 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.
- F3. The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).
Key Figures
RSUs converted July 30, 2026: 11,769 units
RSUs converted July 31, 2026: 11,694 units
Total RSUs converted: 23,463 units
+5 more
8 metrics
RSUs converted July 30, 2026
11,769 units
Restricted stock units converted into common stock on 2026-07-30
RSUs converted July 31, 2026
11,694 units
Restricted stock units converted into common stock on 2026-07-31
Total RSUs converted
23,463 units
Sum of RSUs converted on July 30–31, 2026
Shares withheld July 30, 2026
3,348 shares
Common shares withheld at $0.50 to cover obligations
Shares withheld July 31, 2026
3,326 shares
Common shares withheld at $0.50 to cover obligations
Total shares withheld
6,674 shares
Total common shares withheld for exercise price or tax liability
RSU grant January 30, 2026
188,315 units
RSUs vesting in 16 equal quarterly installments beginning after grant
Vesting installments
16 installments
Time-based vesting for RSU grants beginning one quarter after grant dates
Key Terms
Restricted Stock Units, time-based vesting schedule, Date of Grant, exercise price or tax liability
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
time-based vesting schedule financial
"RSUs vest in 16 equal quarterly installments under a time-based vesting schedule"
Date of Grant financial
"On January 30, 2026, the reporting person was granted RSUs as of the Date of Grant"
exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity transactions did Heron Therapeutics (HRTX) executive William P. Forbes complete on July 30–31, 2026?
Executive William P. Forbes converted 23,463 restricted stock units into common stock over July 30–31, 2026, with 6,674 shares of common stock withheld at $0.50 per share to satisfy exercise price or tax-related obligations tied to the RSU vesting.
How many RSUs did HRTX’s William P. Forbes convert into Heron Therapeutics common stock?
William P. Forbes converted 23,463 restricted stock units into an equal number of Heron Therapeutics common shares. This consisted of 11,769 RSUs converted on July 30, 2026, and 11,694 RSUs converted on July 31, 2026, reflecting scheduled time-based vesting.
What is the vesting structure of William P. Forbes’s RSU grants at Heron Therapeutics (HRTX)?
One RSU grant of 188,315 units dated January 30, 2026 vests in 16 equal quarterly installments. Another RSU grant dated January 31, 2025 also vests in 16 equal installments, beginning one quarter after its grant date, using a time-based vesting schedule.
What does each restricted stock unit reported for HRTX’s William P. Forbes represent?
Each restricted stock unit reported for William P. Forbes represents a contingent right to receive one share of Heron Therapeutics common stock. As the RSUs vest, they are settled in common shares, which can then be subject to share withholding for related obligations.